Hennessy Advisors Inc’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Hennessy Advisors Inc's BIIB Position: Q1 2022 in Review
Hennessy Advisors Inc sold out of Biogen (BIIB) in Q1 2022, closing a stake of 9,500 shares — an estimated $2.28M sold.
Hennessy Advisors Inc first reported a position in BIIB in Q4 2013 and held it in 15 quarters. The position peaked at $3.5M in Q2 2021. 951 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.
- Hennessy Advisors Inc reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
- Hennessy Advisors Inc sold 9,500 Biogen shares in Q1 2022, an estimated $2.28M.
- Hennessy Advisors Inc first reported a position in Biogen in Q4 2013 and held it in 15 quarters.
- Hennessy Advisors Inc's Biogen position peaked at $3.5M in Q2 2021.
- 951 funds tracked by Wall St. Rank held Biogen as of Q1 2022.
Based on Hennessy Advisors Inc's 13F filing for Q1 2022, filed 12 May 2022.